How ValueAct may bring an amicable approach to help boost margins at this Japanese medical device company
January 6, 2024 Comments Off
ValueAct Capital has a stake in Nihon Kohden. The firm’s approach with Olympus and JSR may give an indication of how ValueAct will move forward from here.
How ValueAct may bring an amicable approach to help boost margins at this Japanese medical device company
ValueAct Capital has a stake in Nihon Kohden. The firm’s approach with Olympus and JSR may give an indication of how ValueAct will move forward from here.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender